Sinutab

Annual revenue: US$ 74.3 billion <img alt="Increase" src="../I/m/Increase2.svg.png" data-file-width="300" data-file-height="300" data-file-type="drawing" height="11" width="11"> ( FY 2014)
Annual net income: US$ 16.3 billion <img alt="Increase" src="../I/m/Increase2.svg.png" data-file-width="300" data-file-height="300" data-file-type="drawing" height="11" width="11"> ( FY 2014)
Employees: 118,700

Sinutab is a sinus, allergy and pain relief medication manufactured and distributed by the Johnson & Johnson corporation. It is packaged as white, round, biconvex, uncoated tablets, with each tablet containing 30 mg of pseudoephedrine hydrochloride, 500 mg of paracetamol and 2 mg of chlorpheniramine maleate as the active ingredients.^[1]

References

Johnson & Johnson

CEOs and presidents	Current: Alex Gorsky, Chairman and CEO Robert Wood Johnson I James Wood Johnson Robert Wood Johnson II Robert Wood Johnson III Philip B. Hofmann Richard B. Sellars James E. Burke Ralph S. Larsen

Selected subsidiaries	ALZA Corporation Cilag Crucell DePuy, Inc. Ethicon Endo-Surgery, Inc. Ethicon, Inc. Independence Technology, LLC J&J PRD Janssen Biotech Janssen Pharmaceutica LifeScan McNeil Consumer & Specialty Pharmaceuticals McNeil Nutritionals Ortho-McNeil Pharmaceutical Ortho-Neutrogena Penaten Tibotec

Major brands	Acuvue Aveeno Band-Aid Benadryl Benecol (US license) Caladryl Clean & Clear Desitin Imodium Johnson's Baby Lactaid Listerine Motrin Mylanta Mylicon Neosporin Neutrogena OneTouch Pepcid Plax Rembrandt Splenda Sudafed Tylenol Visine

Annual revenue: US$74.3 billion (FY 2014) Annual net income: US$16.3 billion (FY 2014) Employees: 118,700

This article is issued from Wikipedia - version of the 1/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.